ClinicalTrials.gg
Sign In

Pancreatic Diseases clinical trials

The registry lists 184 studies for Pancreatic Diseases across more than 10 countries. 63 are recruiting or about to start. 65 of them are mainly about Pancreatic Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05. Counting its 24 narrower conditions too, such as Pancreatic Neoplasms: 6,873 studies, 1,566 open.

Get an email when these change. Save the Pancreatic Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
78
Recruiting
43
Status unknown
24
Not yet recruiting
18
Terminated
9
Withdrawn
5

Phase

Phase 2
24
Phase 3
15
Phase 4
8
Phase 1
7

Where

United States
60
China
23
Italy
21
Canada
17
France
16
Germany
12

Who runs them

IRCCS San Raffaele (8) · Changhai Hospital (7) · Vertex Pharmaceuticals Incorporated (5) · Indiana University (3) · Ruijin Hospital (3) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (3) · Istituto Clinico Humanitas (3) · Stanford University (3)

What is being tested here

Drugs under test in Pancreatic Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dabrafenib111
Trametinib111
Ondansetron111
Paclitaxel015
Ivacaftor024
Albumin-Bound Paclitaxel013
Ersodetug012
Gemcitabine002
Submicron Particle Paclitaxel Sterile Suspension002
MK-4721002

Drug classes tested here Antimitotic agents 5

Coming up

3phase 3 studies under way
22studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 43 Pancreatic Diseases studies recruiting now, 25 (58%) set no upper age limit and 4 (9%) stop at 75 or younger. 7 (16%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 8 (19%) take healthy volunteers.

Recruiting studies that take each age, of 43
AgeWomenMen
105 (12%)5 (12%)
1841 (95%)41 (95%)
3041 (95%)41 (95%)
4041 (95%)41 (95%)
5041 (95%)41 (95%)
6541 (95%)41 (95%)
7540 (93%)40 (93%)
8536 (84%)36 (84%)

Across all 184 studies, recruiting or not: 10% stop at 75 or younger and 7% at 65; 21% take children; 0% are for women only and 1% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Pancreatic Diseases studies take

Of 44 observational studies under Pancreatic Diseases, half reached primary completion within 67 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase35 mo20–44 · 32 studies——
Observational67 mo22–119 · 44 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting1

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 184. Browse all 184 → or search them.